The Wistar Institute
The Wistar Institute is seeking a Post-Doctoral Fellow to join Dr. Christopher McGinnis's laboratory to study tumor-immune interactions during metastasis in breast cancer and osteosarcoma. The role involves utilizing cutting-edge technologies such as single-cell genomics and in vivo mouse models to understand how tumors co-opt the immune system. The long-term goal is to translate basic biological insights into the development of anti-metastatic immunotherapies.
Headquarters
Philadelphia, Pennsylvania, United States
Company Size
201-500 employees
Founded
1892
The Wistar Institute is a global leader in biomedical research specializing in cancer, immunology, infectious diseases, and vaccine development. Founded in 1892 as the nation’s first independent biomedical research institution, Wistar conducts basic and translational research while training the next generation of scientific leaders. The institute advances discovery through collaborations with academia, industry, and public health partners and supports the broader innovation ecosystem to translate findings into therapies, vaccines, and public-health tools.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for The Wistar Institute.
The Wistar Institute didn’t post a salary, so this is our estimate from similar listings.
POSTDOCTORAL RESEARCHER - Metastasis Research - Malladi Lab [Req#: 918792, Position#: 120557]
UT Southwestern Medical Center
Postdoctoral Scientist
Oracle
Life Science Research Professional 2
Oracle
POSTDOCTORAL RESEARCHER - Metastasis Research - Malladi Lab [Req#: 922480, Position#: 97785]
UT Southwestern Medical Center
Research Position
oraclecloudinfrastructure
Life Science Research Professional 2
Oracle